1 – 10 of 2160
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Recombinant factor IX Fc for the treatment of hemophilia B
2024) In European Journal of Haematology(
- Contribution to journal › Scientific review
-
Mark
LIN28B promotes differentiation of fully transformed AML cells but is dispensable for fetal leukemia suppression
2024) In Leukemia(
- Contribution to journal › Letter
-
Mark
Genome-wide CRISPR/Cas9 screen identifies regulators of BCMA expression on multiple myeloma cells
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Ontogeny shapes the ability of ETV6::RUNX1 to enhance hematopoietic stem cell self-renewal and disrupt early lymphopoiesis
2024) In Leukemia(
- Contribution to journal › Letter
-
Mark
Evidence that CD36 is expressed on red blood cells and constitutes a novel blood group system of clinical importance
(
- Contribution to journal › Article
-
Mark
Red blood cell-derived arginase release in hemolytic uremic syndrome
(
- Contribution to journal › Article
- 2023
-
Mark
Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation
2023) In Leukemia(
- Contribution to journal › Article
-
Mark
Desialylated Platelet Clearance in the Liver is a Novel Mechanism of Systemic Immunosuppression
(
- Contribution to journal › Article
-
Mark
Infrastructural considerations of implementing gene therapy for hemophilia in the Nordic context
(
- Contribution to journal › Article
-
Mark
The role of T cells and myeloid-derived suppressor cells in refractory immune thrombocytopenia
(
- Contribution to journal › Scientific review